- If approved, investigational semaglutide 7.2 mg injection would offer the optionality of a higher dose for greater weight loss potential in adults with obesity1,2
- In the STEP UP…
Novo Nordisk files for FDA approval of a higher dose of Wegovy® injection 7.2 mg
